Sera Prognostics, Inc.
SERANasdaqCIK 1534969HealthcareFiscal year ends Dec 31
Reports and events: 86 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1921:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-357112 |
| 2026-08-1220:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-346862 |
| 2026-08-1220:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-346846 |
| 2026-06-3020:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001534969-26-000035 |
| 2026-06-0421:13 ET | 8-K | 5.07 Shareholder vote results | 0001534969-26-000032 |
| 2026-06-0120:44 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001534969-26-000028 |
| 2026-05-0620:08 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001534969-26-000025 |
| 2026-05-0620:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534969-26-000024 |
| 2026-04-2420:10 ET | DEF 14A | Proxy statementPeriod 2026-04-23 | 0001534969-26-000018 |
| 2026-03-1820:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001534969-26-000009 |
| 2026-03-1820:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534969-26-000008 |
| 2026-01-0822:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-007850 |
| 2026-01-0714:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-005531 |
| 2025-11-2413:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-292074 |
| 2025-11-1321:12 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-280182 |
| 2025-11-1321:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-280167 |
| 2025-09-0520:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001534969-25-000005 |
| 2025-08-0620:09 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104007 |
| 2025-08-0620:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-103994 |
| 2025-06-0521:28 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-082539 |
| 2025-05-0821:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-067231 |
| 2025-05-0720:12 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-065667 |
| 2025-05-0720:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065654 |
| 2025-04-2320:10 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0000950170-25-057359 |
| 2025-03-1920:16 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-042017 |
| 2025-03-1920:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-042005 |
| 2025-02-1422:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-014395 |
| 2025-02-1421:33 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-25-014220 |
| 2025-02-1201:46 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-024518 |
| 2025-02-1021:08 ET | 8-K | 8.01 Other events | 0001193125-25-023577 |
| 2025-01-3118:31 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-018170 |
| 2025-01-1322:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004909 |
| 2025-01-0722:21 ET | 8-K | 7.01 Regulation FD disclosure | 0000950170-25-003021 |
| 2024-11-0621:11 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122312 |
| 2024-11-0621:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122288 |
| 2024-08-0720:14 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001534969-24-000152 |
| 2024-08-0720:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534969-24-000151 |
| 2024-06-0620:06 ET | 8-K | 5.07 Shareholder vote results | 0001534969-24-000122 |
| 2024-05-0820:13 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001534969-24-000085 |
| 2024-05-0820:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534969-24-000084 |
| 2024-04-2320:06 ET | DEF 14A | Proxy statementPeriod 2024-06-06 | 0001534969-24-000077 |
| 2024-03-2020:10 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001534969-24-000055 |
| 2024-03-2020:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001534969-24-000054 |
| 2023-12-1221:05 ET | 8-K | 1.01 Entry into a material agreement | 0001534969-23-000127 |
| 2023-12-0613:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001534969-23-000121 |
| 2023-11-0821:10 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001534969-23-000112 |
| 2023-11-0821:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534969-23-000111 |
| 2023-09-2512:52 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001534969-23-000096 |
| 2023-08-0920:13 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001534969-23-000092 |
| 2023-08-0920:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534969-23-000091 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.